SCHEMBL10073936

SCHEMBL10073936

COC1C(CO)OC(OC2C(CO)OC(OC(C)C)C(O)C2O)C(O)C1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AMY2A P04746 2/20 0.53
▸ TYR P14679 4/20 0.47
▸ AMY1A P0DUB6 2/20 0.44
▸ LGALS3 P17931 2/20 0.44
▸ LGALS8 O00214 1/20 0.44
▸ LGALS4 P56470 1/20 0.44
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ LGALS9 O00182 1/20 0.39
▸ LGALS1 P09382 1/20 0.39
▸ LGALS7; LGALS7B P47929 1/20 0.39
▸ GAA P10253 4/20 0.38
▸ MGAM O43451 2/20 0.38
▸ SI P14410 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ MGAM2 Q2M2H8 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27416662 1.00 AMY2A (0.53) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL16234072 0.94 AMY2A (0.45) AMY2ATYRAMY1ALGALS8MGAM
SCHEMBL13716367 0.94 AMY2A (0.45) AMY2ATYRAMY1ALGALS8MGAM
SCHEMBL15958439 0.93 AMY2A (0.47) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL10047647 0.91 TYR (0.48) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL17341181 0.91 TYR (0.48) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL12902015 0.90 TYR (0.56) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL12563490 0.90 TYR (0.56) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL12604931 0.90 TYR (0.56) AMY2ATYRAMY1ALGALS3LGALS8
SCHEMBL12901988 0.90 TYR (0.56) AMY2ATYRAMY1ALGALS3LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120052107-A9 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF SURMODICS MD, LLC 2012-03-01 — — US disclosed
US-20110159067-A1 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF SURMODICS, INC. 2011-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052107-A9 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF CD44, FUT6, FUT5 AMY2A 1526/4885TYR 506/4885AMY1A 720/4885
US-20110159067-A1 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF CD44, FUT6, FUT5 AMY2A 1526/4885TYR 506/4885AMY1A 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback